PRECISION BIOSCIENCES INC (DTIL) SEC Filings & Financial Intelligence
PRECISION BIOSCIENCES INC (DTIL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DTIL
CIK: 1357874
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 05/21
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerBeth Prophet-Reese
Audit LocationRaleigh, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-11-06 | — | 144 Filing | 0001959173-26-007836 | View SEC Doc Filr Page |
| 8-K | 2026-11-06 | 2026-11-05 | 8-K | 0001628280-26-071304 | View SEC Doc Filr Page |
| 424B5 | 2026-11-06 | — | 424B5 | 0001628280-26-071249 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001959173-26-007799 | View SEC Doc Filr Page |
| FWP | 2026-11-05 | — | FWP | 0001628280-26-070552 | View SEC Doc Filr Page |
| 8-K | 2026-11-05 | 2026-11-05 | 8-K | 0001628280-26-070542 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-11-03 | — | SCHEDULE 13G/A Filing | 0001214659-26-013679 | View SEC Doc Filr Page |
| 8-K | 2026-11-03 | 2026-11-03 | 8-K | 0001628280-26-069115 | View SEC Doc Filr Page |
| 10-Q | 2026-11-03 | 2026-09-30 | 10-Q | 0001628280-26-069092 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-27 | — | SCHEDULE 13G Filing | 0002012383-26-003830 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001628280-26-063980 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | FORM 4 | 0001628280-26-063767 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | FORM 4 | 0001628280-26-063766 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-24 | — | SCHEDULE 13G/A Filing | 0002033801-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | 8-K | 0001628280-26-058512 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001628280-26-054602 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-053837 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-053836 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-01 | FORM 3 | 0001628280-26-051531 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-01 | FORM 3 | 0001628280-26-051530 | View SEC Doc Filr Page |
| 3 | 2026-08-03 | 2026-08-01 | FORM 3 | 0001628280-26-051529 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0000919574-26-004663 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-23 | 8-K | 0001628280-26-049665 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-20 | — | SCHEDULE 13G Filing | 0000902664-26-003172 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | 8-K | 0001628280-26-046340 | View SEC Doc Filr Page |